Pfizer last week said that it is seeking emergency approval from US regulators for its Covid-19 vaccine, which has shown 95 percent efficacy in a totality of two data sets.
Factors such as education level, fear of outcome affects attitudes; there is time to educate people, officials say
The Central Drug Standard Control Organisation has granted permission for manufacture of COVID-19 vaccine for pre-clinical test, examination and analysis to seven firms
The communique comes as at least two vaccine makers are planning to apply for emergency use authorisation for the vaccines, developed abroad but planned to be produced in India.
Pune Divisional Commissioner Saurabh Rao said there was a possibility that Prime Minister Narendra Modi would also visit Pune.
In a virtual review meeting, Modi laid special emphasis on eight high burden states, including Haryana, Delhi, Chhattisgarh, Kerala, Maharashtra, Rajasthan, Gujarat and West Bengal.
Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II trials.
The vaccine is likely to be the first Covid-19 vaccine available in India.
Even immunisation of children had its share of difficulties with many people not vaccinating, he said.
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
China has been giving experimental Covid-19 vaccines to people including state employees, international students and essential workers heading abroad since July.
The minister said one can protect oneself from this deadly virus with small precautions like wearing a good quality mask properly, maintaining social distance and taking care of hand-hygiene.
In a virtual roundtable with healthcare workers on COVID-19, Biden alleged on Wednesday that his transition team has not been receiving any cooperation from the Trump administration.
Presently, phase two trials of Covishield, Oxford University’s COVID-19 vaccine, are ongoing in the state
She said the grant does not cover the actual cost of vaccine and distribution expenses, which will be made separately as and when the vaccine is available.